Close
Almac
Achema middle east

Press Releases

Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine Against Novel Coronavirus

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, and Lonza Ltd. announced a 10-year strategic collaboration agreement to enable larger scale manufacture of...

Fujifilm Diosynth Biotechnologies Teams with COVID-19 Therapeutics Accelerator

FUJIFILM Diosynth Biotechnologies, a world leading biologics-Contract Development and Manufacturing Organization (CDMO), announced that it will reserve manufacturing capacity for a future COVID-19 therapy for the COVID-19 Therapeutics Accelerator. The Therapeutics Accelerator is an initiative launched by the Bill...

WuXi Biologics Successfully Completes PFS Filling at its Robotic Aseptic Filling Facility

WuXi Biologics, a global company with leading open-access biologics technology platforms, announced that its robotic aseptic filling isolator facility (DP4) has successfully completed the filling of two batches of pre-filled syringes (PFS). Using Vanrx SA25 to fill the two batches,...

Hardy Diagnostics announces FDA EUA for antibody test and increases manufacturing capacity for COVID-19 products

Hardy Diagnostics, a medical device manufacturer based in Santa Maria, California, announced FDA EUA approval on April 24th for a new in vitro diagnostic medical device: Anti-SARS-CoV-2 Rapid Test (Cat. No. RTA0203). This immunoassay is intended for qualitative detection and...

ProteoGenix to accelerate the discovery of SARS-CoV-2 antibodies with first human immune COVID-19 library

ProteoGenix, a global leader in antibody production, is pleased to announce the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2. "Highly sensitive and specific antibodies are critical for the development of diagnostics, therapeutics, and...

Elsevier adds to its extensive free resources for biomedical and scientific researchers working on coronavirus with access to broad suite of tools

Elsevier, a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and life science companies accelerate efforts to address the current...

Genalyte Announces Availability of its High-Speed COVID-19 Antibody Test

Genalyte, the company empowering physicians and patients with real-time diagnostics and healthcare analytics, announced the availability of its rapid COVID-19 serology panel on its Maverick™ platform. The panel tests for the detection of IgG and IgM antibodies that the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »